Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-030720
Filing Date
2019-05-17
Accepted
2019-05-17 11:46:06
Documents
1
Period of Report
2019-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4396
  Complete submission text file 0001209191-19-030720.txt   5757
Mailing Address 525 UNIVERSITY AVE SUITE 1350 PALO ALTO CA 94301
Business Address
SCHNELL DAVID (Reporting) CIK: 0001162060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38853 | Film No.: 19834770

Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Issuer) CIK: 0001426332 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations